Tenax Therapeutics TENX
NASDAQ TENX
$1.76 +0.13 (+7.98%)
At close: Oct 22, 2026 · 4:00 PM EDT

Tenax Therapeutics (TENX) Non-Current Deferred Tax Liability (2021)

Updated

Tenax Therapeutics (TENX) recorded Non-Current Deferred Tax Liability of $211,590 in Q3 2021, down 11.5% from the prior quarter.

Analysis

Tenax Therapeutics (TENX) Non-Current Deferred Tax Liability (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Tenax Therapeutics 91.31 Mn -342.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 211,590.00
Jun 30, 2021 239,039.00
API Access

Tenax Therapeutics Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=TENX&period=max&api_key=YOUR_API_KEY